VRNA β€” Verona Pharma PLC

Ownership history in SYQUANT CAPITAL SAS  Β·  1 quarter on record

This page tracks every 13F SEC filing in which SYQUANT CAPITAL SAS reported a position in Verona Pharma PLC (VRNA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β€” sourced directly from SEC EDGAR 13F filings.

πŸ” Peak position
37.01% (2025 Q3)
πŸ“Š Avg. % of fund
37.01%
πŸ“… First filed
2025 Q3
πŸ“… Last filed
2025 Q3
⏱ Quarters held
1
% of Fund (quarterly)
πŸ“‹ Quarterly Holdings History 1 quarter  β–Ύ
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 INITIATED 1,208,312 β€” β€” 37.01% $128.9M β€”

🏒 Other funds also holding VRNA

As of 2025 Q3 β€” sorted by position size

Twin Securities, Inc. 3Y 7Y 26.58% Vazirani Asset Management LLC 3Y 22.88% Aisling Capital Management LP 3Y 7Y 14.39% NEA Management Company, LLC 3Y 7Y 13.19% OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 3Y 7Y 12.73% Chicago Capital Management, LLC 3Y 7Y 12.37% Vivo Capital, LLC 3Y 7Y 11.97% KRYGER CAPITAL Ltd 3Y 11.86% GLAZER CAPITAL, LLC 3Y 7Y 11.48% Taconic Capital Advisors LP 3Y 7Y 10.86%
← Back to SYQUANT CAPITAL SAS Holdings